Finance Watch: Though Flush With Cash, Theseus Seeks Alternatives, Gets Two Quick Offers
With Shallow Funds, BrainStorm, Atreca, SQZ Make Deep Cuts
Restructuring Edition: OrbiMed/Foresite and Concentra responded quickly after Theseus implemented a 72% workforce reduction and began a search for strategic alternatives despite having $225.4m in cash. REGENXBIO, Novavax and Lyell also revealed job cuts despite large cash stockpiles.
